EHR Technology: Where Meaningful Use, Compliance, and Clinical IT Intersect
Web Conference
18 November 2015
This program, hosted by Foley’s Digital Health team, features a panel of experienced provider experts, consultants, and counsel who will discuss several hot EHR-related topics, such as:
- The New Stage 3 Meaningful Use Regulations — What do hospitals and eligible professionals need to know?
- Meaningful Use Audits — What are they and how do you prepare for them?
- Key EHR Compliance Risks — A look at templates, copy-and-paste functions, and other tools
- The Future Direction of HIT — What’s next on the federal government’s agenda?
Presenters
- M. Leeann Habte, Senior Counsel, Foley & Lardner LLP
- Ryan Haggerty, Senior Manager, Deloitte & Touche LLP
- Cathy Mechsner, Project Manager HIT, L.A. Care Health Plan
- Richard K. Rifenbark, Partner, Foley & Lardner LLP
RSVP
There is no cost to participate in this program, but pre-registration is required. To participate, please use the Register Today button above or below, or simply register here. Instructions for accessing the program will be included in the registration confirmation email.
We look forward to having you join us. For more information, please visit Foley.com or contact Zulaikha Rahim at [email protected].
CLE
Foley & Lardner LLP will apply for CLE credit after the program, wherever applicable. Foley & Lardner LLP certifies that this activity has been approved for California MCLE credits by the State Bar of California in the amount of one General credit. Foley & Lardner LLP is a State Bar of California MCLE approved provider. Please note that participants must log in to the web portion on the date of the event and answer the CLE polling question; credit may not be obtained by viewing and/or listening to a program recording after the event. Certificates of attendance will be distributed to eligible participants approximately 8 weeks after the web conference via email.
Important Information for New York Attorneys
This program is appropriate for experienced attorneys only. Attorneys admitted two years or less are not eligible to earn CLE credit through the completion of courses in nontraditional formats.
Related Insights
April 14, 2026
Health Care Law Today
FDA Clarifies Policies for Pharmacy Compounders of GLP-1 Products
On April 1, 2026,the U.S. Food & Drug Administration (FDA) issued a statement clarifying its compliance policy on the conditions that must be met for compounded drugs to qualify for the exemptions under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
April 14, 2026
Foley Career Perspectives
Trust Your Instincts: Susan Pravda on Leadership, Relationships, and Resilience
Foley partner Susan Pravda is a business lawyer focused on mergers and acquisitions, venture capital, initial public offerings, and related securities transactions and is head of Foley’s Health Care & Life Sciences Sector. She also serves as the firm’s chief strategic talent acquisition partner.
April 14, 2026
Blogs
When to Litigate and When to Walk Away
Clients faced with defending or initiating litigation often begin with the question: “Can we win?” The question sounds simple enough, and if the law is favorable, the instinctive answer might be “yes.” But “winning” in court doesn’t happen, and can’t be evaluated, in a vacuum. In reality, the odds of success in litigation depend not only on the law and facts of the case but also on any business constraints and potential consequences.